The postoperative C-reactive protein level can be a useful prognostic factor for poor outcome and symptomatic vasospasm in patients with aneurysmal subarachnoid hemorrhage

Journal of Neurosurgical Anesthesiology

Volumn 24, Issue 4, 2012, Pages 317-324

  Jeon, Young Tae ^a   Lee, Ju Hyun ^b   Lee, Hannnah ^b   Lee, Hye Kyoung ^b   Hwang, Jung Won ^a   Lim, Young Jin ^b   Park, Hee Pyoung ^b  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

C reactive protein; cerebral aneurysm; poor outcome; subarachnoid hemorrhage; symptomatic vasospasm

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANEURYSM SURGERY; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN DECOMPRESSION; BRAIN INFARCTION; BRAIN VASOSPASM; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEUROSURGERY; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NEUROSURGICAL PROCEDURES; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; ROC CURVE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL;

EID: 84866365064     PISSN: 08984921     EISSN: 15371921     Source Type: Journal    
DOI: 10.1097/ANA.0b013e31826047a2     Document Type: Article

References (25)

1. Kassell NF, Torner JC, Haley EC Jr, et al. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg. 1990;73:18-36.
2. Brisman JL, Song JK, Newell DW. Cerebral aneurysms. N Engl J Med. 2006;355:928-939.
3. Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: A systematic review and metaanalyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151:483-495.
4. Elkind MS, Luna JM, Moon YP, et al. High-sensitivity C-reactive protein predicts mortality but not stroke: The Northern Manhattan Study. Neurology. 2009;73:1300-1307.
5. Nordestgaard BG, Zacho J. Lipids, atherosclerosis and CVD risk: Is CRP an innocent bystander? Nutr Metab Cardiovasc Dis. 2009;19:521-524.
6. Graetz D, Nagel A, Schlenk F, et al. High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage. Neurol Res. 2010;32:728-735.
7. Fountas KN, Tasiou A, Kapsalaki EZ, et al. Serum and cerebrospinal fluid C-reactive protein levels as predictors of vasospasm in aneurysmal subarachnoid hemorrhage. Clinical article. Neurosurg Focus. 2009;26:22-31.
8. Juvela S, Kuhmonen J, Siironen J. C-reactive protein as predictor for poor outcome after aneurysmal subarachnoid haemorrhage. Acta Neurochir. 2012;154:397-404.
9. Kasius KM, Frijns CJ, Algra A, et al. Association of platelet and leukocyte counts with delayed cerebral ischemia in aneurismal subarachnoid hemorrhage. Cerebrovasc Dis. 2010;29:576-583.
10. Kubo Y, Ogasawara K, Kakino S, et al. Serum inflammatory adhesion molecules and high-sensitivity C-reactive protein correlates with delayed ischemic neurologic deficits after subarachnoid hemorrhage. Surg Neurol. 2008;69:592-596.
11. Rothoerl RD, Axmann C, Pina AL, et al. Possible role of the C-reactive protein and white blood cell count in the pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg Anesthesiol. 2006;18:68-72.
12. Sarrafzadeh A, Schlenk F, Gericke C, et al. Relevance of cerebral interleukin-6 after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2010;13:339-346.
13. Hoh BL, Topcuoglu MA, Singhal AB, et al. Effect of clipping, craniotomy, or intravascular coiling on cerebral vasospasm and patient outcome after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2004;55:779-786.
14. Yin L, Ma CY, Li ZK, et al. Predictors analysis of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Acta Neurochir Suppl. 2011;110:175-178.
15. McGirt MJ, Mavropoulos JC, McGirt LY, et al. Leukocytosis as an independent risk factor for cerebral vasospasm following aneurismal subarachnoid hemorrhage. J Neurosurg. 2003;98:1222-1226.
16. Hirashima Y, Hamada H, Kurimoto M, et al. Decrease in platelet count as an independent risk factor for symptomatic vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2005;102:882-887.
17. Frontera JA, Claassen J, Schmidt JM, et al. Prediction of symptomatic vasospasm after subarachnoid hemorrhage: The modified fisher scale. Neurosurgery. 2006;59:21-27.
18. Lu H, Shi JX, Chen HL, et al. Expression of monocyte chemoattractant protein-1 in the cerebral artery after experimental subarachnoid hemorrhage. Brain Res. 2009;1262:73-80.
19. Wang Z, Wang KY, Wu Y, et al. Potential role of CD34 in cerebral vasospasm after experimental subarachnoid hemorrhage in rats. Cytokine. 2010;52:245-251.
20. Takizawa T, Tada T, Kitazawa K, et al. Inflammatory cytokine cascade released by leukocytes in cerebrospinal fluid after subarachnoid hemorrhage. Neurol Res. 2001;23:724-730.
21. Rosengart AJ, Schultheiss KE, Tolentino J, et al. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38:2315-2321.
22. Guresir E, Beck J, Vatter H, et al. Subarachnoid hemorrhage and intracerebral hematoma: Incidence, prognostic factors, and outcome. Neurosurgery. 2008;63:1088-1093.
23. O'Kelly CJ, Kulkarni AV, Austin PC, et al. The impact of therapeutic modality on outcomes following repair of ruptured intracranial aneurysms: An administrative data analysis. Clinical article. J Neurosurg. 2010;113:795-801.
24. Di Napoli M, Godoy DA, Campi V, et al. C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score. Stroke. 2011;42: 1230-1236.
25. Tam AK, Ilodigwe D, Mocco J, et al. Impact of systemic inflammatory response syndrome on vasospasm, cerebral infarction, and outcome after subarachnoid hemorrhage: Exploratory analysis of CONSCIOUS-1 database. Neurocrit Care. 2010;13: 182-189.